Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lipid changes in Duchenne muscular dystrophy.

B P Hughes

    Journal of Neurology, Neurosurgery, and Psychiatry
    |October 1, 1972
    PubMed
    Summary

    Duchenne muscular dystrophy alters muscle lipid composition, increasing sphingomyelin and cholesterol while decreasing lecithin. This lipid profile in dystrophic muscle mirrors that of immature muscle and mouse models.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Inhibition of indoleamine 2,3-dioxygenase activity by fatty acids and prostaglandins: A structure function analysis.

    Prostaglandins, leukotrienes, and essential fatty acids·2017
    Same author

    A comprehensive conceptual framework for road safety strategies.

    Accident; analysis and prevention·2016
    Same author

    System theory and safety models in Swedish, UK, Dutch and Australian road safety strategies.

    Accident; analysis and prevention·2014
    Same author

    A review of models relevant to road safety.

    Accident; analysis and prevention·2014
    Same author

    Some Biochemical Aspects of the Myopathies.

    Postgraduate medical journal·2011
    Same author

    Fast and slow gating of CLC-1: differential effects of 2-(4-chlorophenoxy) propionic acid and dominant negative mutations.

    Molecular pharmacology·2001

    Area of Science:

    • Biochemistry
    • Neuromuscular Disorders
    • Lipidomics

    Background:

    • Duchenne muscular dystrophy (DMD) is a severe genetic disorder affecting muscle tissue.
    • Altered lipid metabolism is implicated in various myopathies.
    • Understanding lipid changes in DMD can provide insights into disease mechanisms.

    Purpose of the Study:

    • To investigate the lipid composition of muscle tissue in patients with Duchenne muscular dystrophy.
    • To compare the lipid profiles of dystrophic muscle with normal, immature, and other neuromuscular disorder tissues.
    • To explore potential similarities between human DMD and animal models of muscular dystrophy.

    Main Methods:

    • Thin-layer chromatography was used to analyze lipid extracts from rectus abdominis and gastrocnemius muscles.
    • Muscle samples were obtained from control individuals and patients with severe sex-linked Duchenne muscular dystrophy.
    • Lipid profiles were compared across different muscle types and conditions.

    Main Results:

    • Dystrophic muscle showed significantly higher sphingomyelin and total cholesterol levels compared to normal muscle.
    • Lecithin and choline plasmalogen levels were reduced in dystrophic muscle.
    • The lipid profile of dystrophic muscle resembled that of immature muscle and hereditary muscular dystrophy in mice.
    • Elevated sphingomyelin was also observed in two cases with peripheral neuropathy.

    Conclusions:

    • The lipid alterations in Duchenne muscular dystrophy suggest a resemblance to immature muscle development.
    • Human DMD shares lipidomic similarities with mouse models of hereditary muscular dystrophy.
    • Sphingomyelin levels may serve as a potential biomarker for certain neuromuscular disorders, including peripheral neuropathy.

    Related Experiment Videos